Journal of Diabetes

Papers
(The H4-Index of Journal of Diabetes is 18. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Mechanisms of diabetic foot ulceration: A review47
Targeting the PI3K/Akt signaling pathway in pancreatic β‐cells to enhance their survival and function: An emerging therapeutic strategy for type 1 diabetes45
Increased DKA at presentation among newly diagnosed type 1 diabetes patients with or without COVID‐19: Data from a multi‐site surveillance registry38
Association of metabolic score for insulin resistance and its 6‐year change with incident type 2 diabetes mellitus31
A comparison of the stress hyperglycemia ratio, glycemic gap, and glucose to assess the impact of stress‐induced hyperglycemia on ischemic stroke outcome30
Determinants of mental health outcomes among people with and without diabetes during the COVID‐19 outbreak in the Arab Gulf Region29
Metformin and growth differentiation factor 15 (GDF15) in type 2 diabetes mellitus: A hidden treasure29
Prevalence and impact of diabetes in hospitalized COVID‐19 patients: A systematic review and meta‐analysis28
Measuring the global, regional, and national burden of type 2 diabetes and the attributable risk factors in all 194 countries27
Metabolic syndrome and clinical outcomes in patients infected with COVID‐19: Does age, sex, and race of the patient with metabolic syndrome matter?26
Does inpatient hyperglycemia predict a worse outcome in COVID‐19 intensive care unit patients?26
Diabetic ketoacidosis drives COVID‐19 related hospitalizations in children with type 1 diabetes25
New‐onset diabetes in “long COVID”24
Clinical characteristics and outcomes of COVID‐19 in patients with type 2 diabetes in Turkey: A nationwide study (TurCoviDia)24
Lower free thyroid hormone levels are associated with high blood glucose and insulin resistance; these normalize with metabolic improvement of type 2 diabetes23
Electrophysiologically verified effects of acupuncture on diabetic peripheral neuropathy in type 2 diabetes: The randomized, partially double‐blinded, controlled ACUDIN trial21
Inhibition of α‐glucosidase and α‐amylase by herbal compounds for the treatment of type 2 diabetes: A validation of in silico reverse docking with in vitro enzyme assays20
Diabetes and stroke: An important complication19
Transparent machine learning suggests a key driver in the decision to start insulin therapy in individuals with type 2 diabetes18
0.24144792556763